News about Global Pharma

World Precision Instruments Launches Next-Generation Multiplexed TEER-on-a-Chip Platform

The co-developed platform integrates WPI's gold-standard EVOM™ measurement technology with SynVivo's SynTEER™ multiplexed OOC models with embedded electrodes, providing researchers with a seamless solution for performing TEER measurements directly within microfluidic chips.

Global Pharma | 12/06/2025 | By Manvi |  291

Moon Surgical Showcases Maestro System at NVIDIA GTC Paris During VivaTech 2025

Moon Surgical announced its participation at NVIDIA GTC Paris during VivaTech2025. In collaboration with NVIDIA, Moon Surgical is highlighting the Maestro System as a pioneering example of Physical AI in action—empowering surgical teams across the globe.

Global Pharma | 12/06/2025 | By Manvi |  118

Broad Institute and Bayer Extend Cardiovascular Research Collaboration by 5 years

The Broad Institute and Bayer have extended their decade-long cardiovascular research collaboration by another five years to accelerate precision cardiology through human genomics and novel therapeutic development.

Global Pharma | 12/06/2025 | By Manvi |  106

Azurity Pharmaceuticals Secures FDA Approval of XIFYRM (meloxicam injection) for Moderate-to-Severe Pain management in Adults

Azurity Pharmaceuticals has received US FDA approval for XIFYRM, a once-daily IV meloxicam injection for moderate-to-severe pain management in adults, offering a non-opioid alternative for multimodal analgesia.

Global Pharma | 12/06/2025 | By Manvi |  206

Axsome Launches SYMBRAVO in US for Acute Migraine Treatment in Adults

Axsome Therapeutics has announced the US prescription availability of SYMBRAVO (meloxicam and rizatriptan), a novel dual-action treatment for acute migraine with or without aura in adults.

Global Pharma | 11/06/2025 | By Manvi |  307

WuXi Biologics and Virogen Biotechnology Enter Commercial Manufacturing Partnership

WuXi Biologics has announced a strategic partnership with Virogen Biotechnology Inc. to support the commercial manufacturing of VG712, a novel immunotherapy targeting T cell dysregulation.

Global Pharma | 11/06/2025 | By Manvi |  261

GT Medical Technologies Appoints James Leech as Chief Financial and Strategy Officer

GT Medical Technologies announced that James Leech, a seasoned financial and operational life sciences leader, has joined the company as Chief Financial and Strategy Officer.

Global Pharma | 11/06/2025 | By Manvi |  205

FDA-Approved WiSE System Begins US Rollout for Leadless Heart Pacing

In a major milestone for heart failure treatment, the first commercial patients in the US have been successfully implanted with the FDA-approved WiSE® System—marking the beginning of a new chapter in leadless left ventricular endocardial pacing (LVEP) for the treatment of heart failure.

Global Pharma | 11/06/2025 | By Manvi |  118

Okomera Opens Pre-Orders for its First Commercial System 'Ocentra'

Okomera opened pre-orders for its first commercial system, Ocentra, unveiled live at the MPS World Summit in Brussels (10–12 June) and Vivatech Paris (11–14 June).

Global Pharma | 10/06/2025 | By Manvi |  330

Solventum Launches Attest Super Rapid VH2O2 Clear Challenge Pack

Solventum, a global MedTech leader at the forefront of infection prevention innovation, announced the launch of its Attest™ Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack.

Global Pharma | 10/06/2025 | By Manvi |  254